Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
10.75
+0.77 (7.72%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Immunic Market Cap
Immunic has a market cap or net worth of $140.25 million as of April 29, 2026. Its market cap has increased by 62.60% in one year.
Market Cap
140.25M
Enterprise Value
125.34M
1-Year Change
62.60%
Ranking
Category
Stock Price
$10.75
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $140.25M, a decrease of -42.43%. That is a compound annual growth rate of -7.54%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Cognition | 141.31M |
| TuHURA Biosciences | 141.14M |
| Connect Biopharma Holdings | 138.48M |
| Kalaris Therapeutics | 138.03M |
| Kazia Therapeutics | 136.55M |
| Equillium | 128.98M |
| Innate Pharma | 127.25M |
| Biomea Fusion | 125.08M |